The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis
Abstract
Background The migration of monocytes into the vessel wall is a critical event leading to the development of atherosclerosis. Monocyte chemoattractant protein-1 (MCP-1) is the main chemotactic factor involved in this phenomenon, and nuclear factor-κB (NF-κB) is one of the nuclear factors controlling its expression. ACE inhibitors have been useful in some experimental models of atherosclerosis. In this work, we addressed the hypothesis that angiotensin II (Ang II) may be implicated in the recruitment of monocytes into the vessel wall through the activation of NF-κB and the induction of MCP-1 expression. Methods and Results Accelerated atherosclerosis was induced in the femoral arteries of rabbits by endothelial desiccation and atherogenic diet for 7 days. Atherosclerotic vessels exhibited an increase in NF-κB–like activity, and p50 and p65 NF-κB subunits were identified as components of this activity. MCP-1 (mRNA and protein) was also expressed in the injured vessels coincidently with the neointimal macrophage infiltration. ACE inhibition with quinapril reduced these three parameters. In cultured monocytic and vascular smooth muscle cells, Ang II elicited an increase in NF-κB activation and MCP-1 expression that was prevented by preincubation of cells with pyrrolidinedithiocarbamate, an inhibitor of NF-κB activation. Conclusions The present data support a role for Ang II in neointimal monocyte infiltration through NF-κB activation and MCP-1 expression in a model of accelerated atherosclerosis in rabbits. Our results suggest that ACE inhibitors may have a beneficial effect in early atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542214 · Cited by 1,718
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V, & Fallon, J. T. (1994) · Circulation · doi:10.1161/01.cir.90.2.775 · Cited by 1,108
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
NF- kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.
Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y., & Okubo, T. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.2052 · Cited by 523
Zeiher, A. M., Fisslthaler, B., Schray-Utz, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.6.980 · Cited by 462
The inducible transcription factor NF-κ B: structure-function relationship of its protein subunits
Grimm, S., & Baeuerle, P. A. (1993) · Biochemical Journal · doi:10.1042/bj2900297 · Cited by 429
Owens, G. K., Loeb, A., Gordon, D., & Thompson, M. M. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.2.343 · Cited by 412
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.
Ross, R. (1993) · PubMed · Cited by 345
Kaneto, H., Morrissey, J., & Klahr, S. (1993) · Kidney International · doi:10.1038/ki.1993.246 · Cited by 292
Tsukada, T., Rosenfeld, M., Ross, R., & Gown, A. M. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.6.601 · Cited by 291
Rakugi, H., Kim, D. K., Krieger, J. E., Wang, D. S., Dzau, V. J., & Pratt, R. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116965 · Cited by 227
Yu, X., Dluz, S., Graves, D. T., Zhang, L., Antoniades, H. N., Hollander, W., Prusty, S., Valente, A. J., Schwartz, C. J., & Sonenshein, G. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6953 · Cited by 220
Effects of Captopril on Atherosclerosis in Cynomolgus Monkeys
Aberg, G., & Ferrer, P. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000005-00010 · Cited by 196
Bellas, R. E., Lee, J. S., & Sonenshein, G. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118313 · Cited by 183
Angiotensin II Activates pp60c-srcin Vascular Smooth Muscle Cells
Ishida, M., Marrero, M. B., Schieffer, B., Ishida, T., Bernstein, K. E., & Berk, B. C. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1053 · Cited by 167
Suzuki, Y. J., Mizuno, M., & Packer, L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.5008 · Cited by 158
Ruiz‐Ortega, M., González, S., Serón, D., Condom, E., Bustos, C., Largo, R., González, E., Ortíz, A., & Egido, J. (1995) · Kidney International · doi:10.1038/ki.1995.476 · Cited by 122
Self-citationAkahoshi, T., Wada, C., Endo, H., Hirota, K., Hosaka, S., Takagishi, K., Kondo, H., Kashiwazaki, S., & Matsushima, K. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360605 · Cited by 115
Takahashi, M., Masuyama, J., Ikeda, U., Kasahara, T., Kitagawa, S., Takahashi, Y., Shimada, K., & Kano, S. (1995) · Circulation Research · doi:10.1161/01.res.76.5.750 · Cited by 107
Kowala, M. C., Grove, R. I., & Åberg, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90037-x · Cited by 98
Binding Sites for Angiotensin II in Human Mononuclear Leucocytes1
Shimada, K., & Yazaki, Y. (1978) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132183 · Cited by 79
Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell Proliferation
Nakajima, T., Kitajima, I., Shin, H., Takasaki, I., Shigeta, K., Abeyama, K., Yamashita, Y., Tokioka, T., Soejima, Y., & Maruyama, I. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2552 · Cited by 75
Ullian, M. E., & Linas, S. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40215-9 · Cited by 66
Goetzl, E. J., Klickstein, L. B., Watt, K. W. K., & Wintroub, B. U. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91488-6 · Cited by 57
Farber, H. W., Rounds, S., & Danilov, S. M. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_b.100 · Cited by 51
Cited by
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,368
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
Metadata
- Authors
- Hernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J.
- Venue
- Circulation
- Published
- 1997-03-18
- Volume
- 95
- Issue
- 6
- Pages
- 1532-1541
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2033199439
- Cited by
- 494
- References
- 34
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.